Health
China’s Clover says its COVID-19 vaccine candidate shows immune response in mice – Reuters
Chinese biotechnology company Clover Biopharmaceuticals said on Tuesday the modified version of its COVID-19 vaccine candidate showed a strong immune response against…
Chinese biotechnology company Clover Biopharmaceuticals said on Tuesday the modified version of its COVID-19 vaccine candidate showed a strong immune response against the original strain of the virus and some variants during animal testing.
Clover said in a statement its vaccine candidate demonstrated a “neutralisation” against the South African, Brazilian and UK variants among mice.
The company is testing a COVID-19 vaccine candidate containing an adjuvant, typically designed to boost the efficacy…
-
Noosa News14 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
General18 hours agoEnglish springer spaniels Kelly and Milo helping fight dieback in Western Australia
-
General7 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final
-
Business23 hours agoTop brokers name 3 ASX shares to buy next week 5 October 2025